This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
PG's Premium P/E Valuation: Value Opportunity or Risky Proposition?
by Rajani Lohia
While Procter & Gamble's near-term outlook suggests challenges due to ongoing tensions, its strategies and execution indicate long-term growth potential.
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Zacks Equity Research
Sector ETF report for FSTA
Is Trending Stock Procter & Gamble Company (The) (PG) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
The Zacks Analyst Blog Highlights like Amazon.com, Procter & Gamble, Abbott and NVE
by Zacks Equity Research
Amazon.com, Procter & Gamble, Abbott and NVE are part of the Zacks top Analyst Blog.
Top Stock Reports for Amazon.com, Procter & Gamble & Abbott
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), The Procter & Gamble Co. (PG) and Abbott Laboratories (ABT), as well as a micro-cap stock NVE Corp. (NVEC).
Is Most-Watched Stock Procter & Gamble Company (The) (PG) Worth Betting on Now?
by Zacks Equity Research
P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Should You Invest in the Consumer Staples Select Sector SPDR ETF (XLP)?
by Zacks Equity Research
Sector ETF report for XLP
Procter & Gamble Company (The) (PG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
Is It Worth Investing in P&G (PG) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for P&G (PG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Procter & Gamble (PG) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Procter & Gamble (PG) have what it takes? Let's find out.
PG Stock Stays Flat After Q1 Earnings: Time to Reassess Your Position?
by Rajani Lohia
Procter & Gamble's Q1 results reflect further revenue slowdown on soft trends across key markets, while productivity actions support the bottom line.
PG Q1 Earnings Beat on Improved Margins, Sales Miss Estimates
by Zacks Equity Research
Procter & Gamble's Q1 results reflect gains from improved pricing, offset by adverse currency adverse currency rates and other impacts.
A Mixed Bag on Mixed Stock Market Data (revised)
by Mark Vickery
Also, will the Fed be forced to stop cutting interest rates this year?
Mixed Housing Market Data for September
by Zacks Equity Research
Mixed Housing Market Data for September.
A Mixed Bag on Mixed Stock Market Data
by Mark Vickery
Also, will the Fed be forced to stop cutting interest rates this year?
P&G (PG) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for P&G (PG) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Procter & Gamble (PG) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 1.58% and 0.88%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Procter & Gamble, Clorox, Church & Dwight and Colgate-Palmolive
by Zacks Equity Research
Procter & Gamble, Clorox, Church & Dwight and Colgate-Palmolive are part of the Zacks top Analyst Blog.
The Zacks Analyst Blog Highlights Procter & Gamble, Clorox, Church & Dwight and Colgate-Palmolive
by Zacks Equity Research
Procter & Gamble, Clorox, Church & Dwight and Colgate-Palmolive are part of the Zacks top Analyst Blog.
Unlocking Q1 Potential of P&G (PG): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for P&G (PG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
Procter & Gamble (PG) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
Procter & Gamble (PG) closed the most recent trading day at $172.51, moving +0.83% from the previous trading session.
Pre-Q1 Earnings: To Buy or Not to Buy Procter & Gamble Stock?
by Rajani Lohia
Gains from strong pricing, cost-saving and productivity measures should aid PG in Q1 amid Greater China issues, geopolitical tensions and currency volatility.
Q3 Earnings Results of U.S. Corporate Giants in Focus
by Zacks Equity Research
Q3 Earnings Results of U.S. Corporate Giants in Focus.
Bank Holiday Ahead of Busy Stock Trading Week
by Mark Vickery
Despite today's day off from econ metrics, we see a pretty busy week ahead.
Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.